Activated Innate Immunity in Childhood: A Novel Treatment Target

Hardy, Olga T.

dc.contributor.author	Hardy, Olga T.
dc.date	2022-08-11T08:08:12.000
dc.date.accessioned	2022-08-23T15:46:14Z
dc.date.available	2022-08-23T15:46:14Z
dc.date.issued	2011-05-20
dc.date.submitted	2011-08-04
dc.identifier.doi	10.13028/fmfe-k620
dc.identifier.uri	http://hdl.handle.net/20.500.14038/27706
dc.description.abstract	Obesity is a state of chronic low grade inflammation with elevated cytokines that contribute to obesity-related co-morbidities. This presentation will include an overview of a Life Sciences Moment Fund project that examined the effects of a multi-component wellness intervention designed to increase physical activity and reduce risk for cardiometabolic disease in overweight adolescents. Selected results suggesting the potential of activated innate immunity in childhood as a novel treatment target will be emphasized.
dc.format	flash_audio
dc.language.iso	en_US
dc.rights	Copyright the Author(s)
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subject	Community Health and Preventive Medicine
dc.subject	Molecular Biology
dc.subject	Nutritional and Metabolic Diseases
dc.subject	Public Health
dc.title	Activated Innate Immunity in Childhood: A Novel Treatment Target
dc.type	Presentation
dc.identifier.legacyfulltext	https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1004&context=cts_retreat&unstamped=1
dc.identifier.legacycoverpage	https://escholarship.umassmed.edu/cts_retreat/2011/presentations/2
dc.identifier.contextkey	2132984
refterms.dateFOA	2022-08-23T15:46:14Z
html.description.abstract	<p>Obesity is a state of chronic low grade inflammation with elevated cytokines that contribute to obesity-related co-morbidities. This presentation will include an overview of a Life Sciences Moment Fund project that examined the effects of a multi-component wellness intervention designed to increase physical activity and reduce risk for cardiometabolic disease in overweight adolescents. Selected results suggesting the potential of activated innate immunity in childhood as a novel treatment target will be emphasized.</p>
dc.identifier.submissionpath	cts_retreat/2011/presentations/2